Banque Cantonale Vaudoise

SEC CIK: 0001793755
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

GANX holding history

Gain Therapeutics, Inc. in every 13F filed by Banque Cantonale Vaudoise, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GANX overview All 13F holders of GANX Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2021

Holdings of GANX by Banque Cantonale Vaudoise, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−3,000−100.0%	Sold out	Holders
Q4 2021	3,000	$16.0K	<0.1%	00.0%	Unchanged	Holders
Q3 2021	3,000	$22.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2021	3,000	$30.0K	<0.1%	+3,000	New	Holders